ARCHIVES

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

ACS Urges Practice Of Insurance Exclusion End Under Reform

February 5, 1993

CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown

October 1, 2010

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

New Grant Program in Physical Activity

March 28, 2003

NCI Programs: Genetic Variations Discovered, Added to NCI Database

June 11, 1999

FDA Designates Zometa For Priority Review.

November 30, 2001